FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

Approval offers groundbreaking one-time treatment for patients with rare, life-threatening immune disease The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Search Menu Search FDA Submit search Featured Report a Product Problem Contact FDA FDA Guidance Documents Recalls, Market Withdrawals and Safety Alerts Press Announcements Warning Letters Advisory Committees En Espa&#241ol Products Food Drugs Medical Devices Radiation-Emitting…

Source: FDA Press Releases